Review on acute pancreatitis attributed to COVID-19 infection

doi:10.3748/wjg.v28.i19.2034

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7195)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

480

WORD

179

HTML

3742

Figures (1-2)

489

Tables (1-3)

444

Sum=5334

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

224

Download

513

Sum=737

Publishing Process of This Article

Item

Count

Browse

404

Download

720

Sum=1124

May 21, 2022 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 21, 2022; 28(19): 2034-2056
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2034

Table 1 Demographic characteristic of cases with suspected coronavirus disease 2019-attributed acute pancreatitis

Patient characteristics	Value
Age, median (range, yr)	42.0 (6-87)
Gender, male/female/NA	37/44/1
Comorbidities
Hypertension	22
Diabetes	15
Dyslipidemia	4
Heart disease	3
Cerebrovascular	0
Respiratory disease	4
Renal dysfunction	5
Obesity	16
Pregnancy	2
Malignancy	2
History of abdominal surgery	13
Others	10
Alcohol consumption, none/low/heavy/NA	53/9/0/20
History of smoking, never/experience/current/NA	32/2/0/48
Severity of COVID-19
Non-severe/severe/critical/NA	35/23/20/4
Symptoms
Fever	49
Breath shortness	16
Cough	28
Dyspnea	18
Sore throat	18
Fatigue	9
Headache	7
Myalgia	10
Anorexia	13
Diarrhea	16
Abdominal pain	75
Nausea	39
Vomiting	48
Others	23
Blood test
WBC, median (range, × 10³/mm³)	13.10 (3.40-230.00)
PLT, median (range, × 10³/mm³)	235.5 (52.0-502.0)
D-Dimer, median (range, μg/mL)	4.9 (0.3-17.7)
Amylase, median (range, U/L)	635 (47-4530)
Lipase, median (range, U/L)	895.5 (35.6-11920.0)
LDH, median (range, U/L)	366.0 (170-3553)
CRP, median (range, mg/dL)	8.5 (0.3-59.7)
Imaging findings (n = 75)
Pancreatic enlargement	42
Peripancreatic fluid collection	33
Peripancreatic inflammatory change	48
Pancreatic ischemic change	12
No change of pancreas	6
Not visualized	2
Severity of acute pancreatitis
Mild/moderate/severe/NA	28/20/28/6
Therapy for COVID-19
Lopinavir/ritonavir	4
Favipiravir	4
Umifenovir	2
Remdesivir	8
Hydroxychloroquine	2
Tocilizumab	2
Corticosteroid (n = 53)	21
Oxygen therapy (n = 69)	42
Mechanical ventilation	19
Therapy for acute pancreatitis
Conservative therapy/surgical drainage/NA	72/4/6
Period of hospitalization, median (range, day)	7.5 (2-76)
Prognosis
Alive/death/NA	69/10/3

RT-PCR: Reverse transcription polymerase chain reaction; IgM: Immunoglobulin M; IgG: Immunoglobulin G; WBC: White blood cell; PLT: Platelet; LDH: Lactate dehydrogenase; CRP: C-reactive protein; NA: Not available; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; COVID-19: Coronavirus disease 2019.

Citation: Onoyama T, Koda H, Hamamoto W, Kawahara S, Sakamoto Y, Yamashita T, Kurumi H, Kawata S, Takeda Y, Matsumoto K, Isomoto H. Review on acute pancreatitis attributed to COVID-19 infection. World J Gastroenterol 2022; 28(19): 2034-2056
URL: https://www.wjgnet.com/1007-9327/full/v28/i19/2034.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i19.2034